Are antibiotics related to oral combination contraceptive failures in the Netherlands? A case-crossover study

Pharmacoepidemiology and Drug Safety

Volumn 21, Issue 8, 2012, Pages 865-871

  Koopmans, Petra C ^a,b   Bos, Jens H J ^b   de Jong van den Berg, Lolkje T W ^b  

^a Department of Occupational Health Services ^*  (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Breakthrough pregnancy; Case control design; Case crossover design; Pharmacoepidemiology; Prescription database; Use of antibiotics

Indexed keywords

ANTIBIOTIC AGENT; ORAL CONTRACEPTIVE AGENT;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BREAKTHROUGH BLEEDING; CASE CONTROL STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DATA BASE; DRUG EXPOSURE; DRUG TREATMENT FAILURE; FEMALE; HUMAN; NETHERLANDS; PHARMACOEPIDEMIOLOGY; PREGNANCY DISORDER; PRESCRIPTION; PRIORITY JOURNAL; RISK; SENSITIVITY ANALYSIS;

EID: 85027941935     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.3267     Document Type: Article

References (14)

1. Bolt HM. Interactions between clinically used drugs and oral contraceptives. Environ Health Perspect 1994; 102 (Supplement 9): 35-38.
2. Weaver K, Glasier A. Interaction between broad-spectrum antibiotics and the combined oral contraceptive pill: a literature review. Contraception 1999; 59: 71-78.
3. Archer JSM, Archer DF. Oral contraceptive efficacy and antibiotic interaction: a myth debunked. J Am Acad Dermatol 2002; 46: 917-923.
4. Dickinson BD, Altman RD, Nielsen NH, et al. Drug interactions between oral contraceptives and antibiotics. Obstet Gynecol 2001; 98: 853-860.
5. Toh S. Mitchell AA, Anderka M, de Jong-van den Berg LTW, Hernández-Díaz S, the National Birth Defects Prevention Study. Antibiotics and oral contraceptive failure-a case-crossover study. Contraception 2011; 83: 418-425.
6. Monster TBM, Janssen WMT, de Jong PE, et al. Pharmacy data in epidemiological studies: an easy to obtain and reliable tool. Pharmacoepidemiol Drug Saf 2002; 11: 379-384.
7. WHO Collaborating Centre for Drugs Statistics Methodology. ATC/DDD Index 2005. 2008.
8. Schirm E, Tobi H, de Jong-van den Berg LTW. Identifying parents in pharmacy data: a tool for the continuous monitoring of drug exposure to unborn children. J Clin Epidemiol 2004; 57: 737-741.
9. Vroom F, de Jong PH, van den Berg PB, Tobi H, de Jong-van den Berg LTW. Gebruik van orale anticonceptiva in de jaren 1994-2002: wel anders, niet minder [Use of oral contraceptives in the years 1994-2002: different but not less]. Ned Tijdschr Geneeskd 2005; 149: 23-28.
10. Barbone F, McMahon AD, Davey PG, et al. Association of road-traffic accidents with benzodiazepine use. Lancet 1998; 352: 1331-1336.
11. Maclure M. 'Why me' versus 'why now'-differences between operational hypotheses in case-control versus case-crossover studies. Pharmacoepidemiol Drug Saf 2007; 16: 850-853.
12. Maclure M, Mittleman MA. Should we use a case-crossover design? Annu Rev Public Health 2000; 21: 193-221.
13. Schirm E, van den Berg P, Gebben HJ, et al. Drug use of children in the community assessed through pharmacy dispensing data. Br J Clin Pharmacol 2000; 50: 473-478.
14. Koren G. The way women perceive teratogenic risk. Can J Clin Pharmacol 2007; 14: e10-e16.